nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
|
Sarin, Shiv Kumar |
|
2019 |
13 |
4 |
p. 353-390 |
artikel |
2 |
Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcome
|
Wang, Hualin |
|
2019 |
13 |
4 |
p. 454-467 |
artikel |
3 |
Association of acute-on-chronic liver failure with vascular liver diseases
|
Shukla, Akash |
|
2019 |
13 |
4 |
p. 399-402 |
artikel |
4 |
Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis
|
Haraguchi, Masafumi |
|
2019 |
13 |
4 |
p. 482-489 |
artikel |
5 |
Biliary features in liver histology of children with autoimmune liver disease
|
Di Giorgio, Angelo |
|
2019 |
13 |
4 |
p. 510-518 |
artikel |
6 |
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
|
Liao, Xia |
|
2019 |
13 |
4 |
p. 440-453 |
artikel |
7 |
Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology
|
Nishida, Naoshi |
|
2019 |
13 |
4 |
p. 416-421 |
artikel |
8 |
Hepatology through the crystal ball
|
Williams, Roger |
|
2019 |
13 |
4 |
p. 403-406 |
artikel |
9 |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
Huang, Yu-Shan |
|
2019 |
13 |
4 |
p. 431-439 |
artikel |
10 |
New treatment-induced adverse effects we need to learn as modern hepatologists
|
Ueno, Yoshiyuki |
|
2019 |
13 |
4 |
p. 391-394 |
artikel |
11 |
Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis
|
Xu, Xiangbo |
|
2019 |
13 |
4 |
p. 468-481 |
artikel |
12 |
Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial
|
Zhou, Ying |
|
|
13 |
4 |
p. 422-430 |
artikel |
13 |
Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial
|
Zhou, Ying |
|
2019 |
13 |
4 |
p. 422-430 |
artikel |
14 |
Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers
|
Nishida, Tsutomu |
|
2019 |
13 |
4 |
p. 407-415 |
artikel |
15 |
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach
|
Ahn, Keun Soo |
|
2019 |
13 |
4 |
p. 490-500 |
artikel |
16 |
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
|
Wang, Bingqiong |
|
2019 |
13 |
4 |
p. 501-509 |
artikel |
17 |
The first Chinese guidelines on the Management of Ascites and its Related Complications in Cirrhosis: a great goal for a great country
|
Angeli, P. |
|
2019 |
13 |
4 |
p. 395-398 |
artikel |